Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
JAMA network open
View this publicationJAMA network open
View this publicationThe Journal of clinical endocrinology and metabolism
View this publicationCritical care (London, England)
View this publicationMicroorganisms
View this publicationNature reviews. Urology
View this publicationImmunological reviews
View this publicationmBio
View this publicationJournal of molecular medicine (Berlin, Germany)
View this publicationCell host & microbe
View this publicationJournal of immunology research
View this publication